reference/13574317

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13574317

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	1208
issn	1744-764X 1474-0338
issueIdentifier	9
pageRange	1203-1208
publicationName	Expert Opinion on Drug Safety
startingPage	1203
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2297d15768830b5e5b00044237616651 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e053629a4ad99f3a4ea04b7812e18365
bibliographicCitation	Liu D, Shen T, Ren C, Xu S, Zhou L, Bai J, Li N, Zhao W, Gao W. The effects of atorvastatin and rosuvastatin on exercise tolerance in patients with coronary heart disease. Expert Opin Drug Saf. 2020 Sep;19(9):1203–8. doi: 10.1080/14740338.2020.1786533. PMID: 32571108.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b1ebc0e6132135094ef1c5d43e0d2ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec66f7463be9a371e62dba4946eb1220 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a67bde238b3372ffc0e172f38ab0ce62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_618378fc316b971bdb1e7fc27ff4abc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_629b186e7cee531264221c55c1a076a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26f6f568742a556a46f97daf4c60f027 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3da2353271c6c9b00c233fd9f9977576 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52caeef7d524d41a34cd221b036c79f2
date	2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1080/14740338.2020.1786533 https://pubmed.ncbi.nlm.nih.gov/32571108
isPartOf	https://portal.issn.org/resource/ISSN/1744-764X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30478 https://portal.issn.org/resource/ISSN/1474-0338
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The effects of atorvastatin and rosuvastatin on exercise tolerance in patients with coronary heart disease
discusses	http://id.nlm.nih.gov/mesh/M0179294 http://id.nlm.nih.gov/mesh/M0001378 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0402344
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D017079Q000187 http://id.nlm.nih.gov/mesh/D000069059Q000008 http://id.nlm.nih.gov/mesh/D000068718Q000008 http://id.nlm.nih.gov/mesh/D003327Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000069059Q000494 http://id.nlm.nih.gov/mesh/D019161Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D019161Q000494 http://id.nlm.nih.gov/mesh/D000068718Q000494 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005080 http://id.nlm.nih.gov/mesh/D000924Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003327Q000503 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000924Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9869776 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87071853 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12086784 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45114162 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347

Total number of triples: 62.